Get startedLog in
    Picture of SciClone Pharmaceuticals (Holdings) logo

    6600 — SciClone Pharmaceuticals (Holdings) News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareSpeculativeMid Cap
    All News

    Brief: Menarini And Sciclone Sign Licensing Agreement To Develop Vaborem In China

    Picture of SciClone Pharmaceuticals (Holdings) logoSciClone Pharmaceuticals (Holdings)
    20/09/2022 10:14
    Sept 20 (Reuters) - 
    * MENARINI AND SCICLONE SIGN EXCLUSIVE LICENSING AGREEMENT
TO
DEVELOP AND COMMERCIALIZE VABOREM® IN CHINA TO TREAT
ANTIMICROBIAL RESISTANT INFECTIONS

Source text for Eikon:  ID:nPn2WTq0ja 
Further company coverage:  6600.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on SciClone Pharmaceuticals (Holdings)

    See all news